-- 
Israeli Stocks: Teva, Mellanox, Bio Light and Elbit Imaging

-- B y   S h o s h a n n a   S o l o m o n
-- 
2011-09-25T14:58:32Z

-- http://www.bloomberg.com/news/2011-09-25/israeli-stocks-teva-mellanox-bio-light-and-elbit-imaging.html
Israel ’s TA-25 Index rebounded from
the biggest decline in almost three weeks, gaining 2.1 percent
to 1,060.29 at the 4:30 p.m. close in Tel Aviv. Investors traded
about 783 million shekels ($211 million) of shares and
convertible securities today, according to Tel Aviv Stock
Exchange data.  The following stocks rose or fell today. Symbols are in
parentheses.  Elbit Imaging Ltd. (EMIT)   climbed 3.4 percent, the most
since Sept. 20, to 8.107 shekels. A unit of the investor in real
estate and medical companies reached a $30 million loan
agreement with Eastgate Property LLC.  Micromedic Technologies Ltd. (MCTC)   gained 2.9 percent
to 2.381 shekels, the highest level since Sept. 6.  Bio Light
Israeli Life Sciences Investments Ltd. (BOLT)  , a developer of
a laser-based technology to treat glaucoma, agreed to buy a
controlling stake in the developer of biomedical markers. The
shares of Bio Light declined 1.9 percent to 0.212 shekel.  Mellanox Technologies Ltd. (MLNX)   retreated for a sixth
day, declining 2.7 percent to 113.40 shekels, the equivalent of
$30.62. The shares of adapter maker that’s part owned by Oracle
Corp. narrowed the gap with the U.S.-traded stock, which
retreated the most since July 2010 last week to $30.26, after
the company announced a share sale.       Teva Pharmaceutical Industries Ltd. (TEVA)   slumped to the
lowest since December 2006, declining 3.1 percent to 130.30
shekels, the equivalent of $35.19. The European Commission
extended its review of the world’s largest drugmaker’s planned
acquisition of Cephalon Inc. The U.S. traded shares lost 8.6
percent last week to $35.26.  To contact the reporter on this story:
Shoshanna Solomon in  Tel Aviv  at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  